Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose pGM169/GL67A in CF
NCT00789867Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Nov 2008
- Primary completion
- Aug 2009
- Modality
- Gene Editing, Gene Silencing, Gene Addition/Replacement
- Countries
- 1
01
Overview
A Phase 2 trial of pGM169 + GL67A in cystic fibrosis (CF), sponsored by Imperial College London. Started Nov 2008; status: completed.
02
Drugs
pGM169 + GL67A
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00789867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789867.